Share Email Print

Proceedings Paper

Treatment of prostate gland adenoma using local microwave hyperthermia and laser
Author(s): N. P. Raikevich; Sergey G. Fediay; V. A. Spirin; B. I. Blumberg; V. S. Lipsky; S. G. Capkov
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

It is widely known that treatment of prostate gland tumors by local microwave hyperthermia is helpful in many clinical cases. Applications of lasers for treating carcinoma of the prostate and benign prostatic hyperplasia have also been reported. However, there is no clear evidence as to which technique is better, so we compared both techniques in clinical investigations. In our studies we used a Thermex apparatus (Technorex, Israel) for microwave hyperthermal curing of prostate gland adenoma in 90 patients. We also used a laser to study how its radiation influences tumors in the prostate gland and which parameters of laser light provide the most efficient treatment. Results of these investigations are presented, along with the results of research in which we combined the techniques of microwave and laser hyperthermia in various ways. Possible avenues for further research and improvement of the techniques are briefly discussed.

Paper Details

Date Published: 1 June 1992
PDF: 2 pages
Proc. SPIE 1643, Laser Surgery: Advanced Characterization, Therapeutics, and Systems III, (1 June 1992); doi: 10.1117/12.137363
Show Author Affiliations
N. P. Raikevich, Saratov Institute of Medicine (Russia)
Sergey G. Fediay, Saratov Institute of Medicine (Russia)
V. A. Spirin, Saratov Institute of Medicine (Russia)
B. I. Blumberg, Saratov Institute of Medicine (Russia)
V. S. Lipsky, Saratov Institute of Medicine (Russia)
S. G. Capkov, Saratov Institute of Medicine (Russia)

Published in SPIE Proceedings Vol. 1643:
Laser Surgery: Advanced Characterization, Therapeutics, and Systems III
R. Rox Anderson, Editor(s)

© SPIE. Terms of Use
Back to Top